Talphera (TLPH)

• Market cap: $36.8M
• 1 day: -1%
• 5 days: -17.82%
• 1 month: -35.86%
• 3 months: -37.88%
• 6 months: 100.74%
• Year to date: -31.99%
• 1 year: 25.28%
• 5 years: -98.3%
• 10 years: -98.88%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13